Committees:
- Finance (Chair)
- ESG
Attributes and Skills Provided to the Board:
- Leadership experience in life sciences and healthcare companies
- Global business experience
- Growth strategies and market expansion
- Public-company director and executive experience
- Mergers & acquisitions / integrations
- Operational experience in capital-intensive, innovation-focused industries
Expertise Provided to the Board:
Tina S. Nova is an industry veteran in life sciences, with deep experience in building and leading successful life science businesses from conception through IPO, including public-company CEO experience. She has deep insights into commercial operations, sales and marketing efforts, and also brings significant experience in mergers, acquisitions and integration, having overseen the sale of several companies as both an executive and director that created value for shareholders. She also provides relevant life sciences executive leadership experience, having held Chief Executive roles at Decipher Biosciences, until its $600 million sale to Veracyte (NASDAQ: VCYT) in 2021, Molecular Stethoscope and Genoptix, which she co-founded and oversaw its $470 million sale to Novartis AG (NYSE: NVS) in 2011.